Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million

News
2024
2023
Archive
Search news articles

October 11, 2022

scPharmaceuticals Announces FDA Approval of FUROSCIX® (furosemide injection), the First and Only Self-administered, Subcutaneous Loop Diuretic for the At-home Treatment of Congestion in Chronic Heart Failure
October 6, 2022

Artiva Announces AB-101 Abstract Accepted for Presentation at Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting
October 6, 2022

Innovation Passport Granted for CRN04777 for the Treatment of Congenital Hyperinsulinism
October 4, 2022

Cidara Therapeutics Receives $11.1 Million Milestone Payment from Mundipharma
October 4, 2022

Arvinas Appoints Paul McInulty as Senior Vice President, Regulatory Affairs
September 30, 2022

CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data for Baxdrostat in Treatment-Resistant Hypertension at the Upcoming 2022 American Heart Association Scientific Sessions
September 30, 2022

scPharmaceuticals Announces Data Presentations at the Heart Failure Society of America 2022 Annual Scientific Meeting
September 28, 2022

Vor Bio Initiates In-house Clinical Manufacturing at Cambridge, MA Headquarters
September 28, 2022

Rallybio Announces Positive Preliminary Results for RLYB212, an anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia
September 27, 2022

Arthur Tzianabos, Ph.D., June Lee, MD, FACCP, and Joseph Loscalzo, MD, PhD Join 5AM Ventures